Keyword Analysis & Research: icpt stock buy or sell
Keyword Research: People who searched icpt stock buy or sell also searched
Search Results related to icpt stock buy or sell on Search Engine
Biotech Stock Roundup: ICPT's Study Data, NVAX Vaccine Gets …
Jul 14, 2022 · You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here. Novavax Gets Authorization for Vaccine: ... (ICPT) : Free Stock Analysis Report Veru Inc. (VERU) : Free Stock ...
DA: 95 PA: 66 MOZ Rank: 92
7 Biotech Stocks to Buy for Q3 | InvestorPlace
Jul 18, 2022 · A positive verdict could prove salubrious for the stock, which is trading at depressed levels. Analysts, on average, expect the stock to rally to $19.17 , suggesting over 500% upside from current ...
DA: 98 PA: 92 MOZ Rank: 78
Intercept Pharma (ICPT) Tops Q2 EPS by 21c; Offers FY22 Revenue …
Aug 03, 2022 · Intercept Pharma (NASDAQ: ICPT) reported Q2 EPS of ($0.25), $0.21 better than the analyst estimate of ($0.46). Revenue for the quarter came in at $71.76 million versus the consensus estimate of ...
DA: 54 PA: 67 MOZ Rank: 16
Intercept (ICPT) Reports Positive Data From NASH Study on OCA
Jul 08, 2022 · Intercept Pharmaceuticals, Inc. (ICPT): Free Stock Analysis Report Aquestive Therapeutics, Inc. (AQST): Free Stock Analysis Report Aridis Pharmaceuticals (ARDS): Free Stock Analysis Report
DA: 27 PA: 94 MOZ Rank: 58
B. Riley Comments on Intercept Pharmaceuticals, Inc.’s Q2 2022 …
Aug 01, 2022 · ICPT opened at $12.76 on Monday. Intercept Pharmaceuticals has a 12-month low of $10.81 and a 12-month high of $20.50. The business’s fifty day simple moving average is $14.51 and its 200-day ...
DA: 92 PA: 81 MOZ Rank: 59
Notable Tuesday Option Activity: LQDA, CARS, ICPT | Nasdaq
Jul 19, 2022 · Amazon to Buy Vacuum Maker iRobot for Roughly $1.7B Aug 05, 2022 Now Playing The Week's Top Stories: Robinhood, Warner Bros. Discovery & …
DA: 90 PA: 3 MOZ Rank: 2
Intercept Pharmaceuticals (ICPT) Reports Q2 Loss, Beats Revenue
Aug 05, 2022 · Intercept Pharmaceuticals (ICPT) came out with a quarterly loss of $0.68 per share versus the Zacks Consensus Estimate of a loss of $0.53. This compares to loss of $0.33 per share a year ago ...
DA: 33 PA: 85 MOZ Rank: 12
Intercept Pharmaceuticals (NASDAQ:ICPT) Downgraded by …
Aug 05, 2022 · Needham & Company LLC decreased their price target on Intercept Pharmaceuticals from $25.00 to $22.00 and set a “buy” rating on the stock in …
DA: 68 PA: 60 MOZ Rank: 53
Intercept (ICPT) Earnings Miss, Sales Top Estimates in Q2 (Revised)
Aug 05, 2022 · Intercept Pharmaceuticals, Inc. (ICPT) incurred a loss of 68 cents per share (from continuing operations) in second-quarter 2022, wider than the Zacks Consensus Estimate of a loss of 53 cents.
DA: 85 PA: 79 MOZ Rank: 41
LXRX Stock Forecast, Price & News (Lexicon Pharmaceuticals)
Aug 09, 2022 · 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Lexicon Pharmaceuticals in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" LXRX shares. View LXRX analyst ratings or view top-rated stocks.
DA: 67 PA: 92 MOZ Rank: 39